Antibiotic Treatment of Common Infections

More Evidence to Support Shorter Durations

Benjamin J. Smith; George Heriot; Kirsty Buising


Curr Opin Infect Dis. 2020;33(6):433-440. 

In This Article

Future Research

Many opportunities exist to improve the evidence base for treatment of common infections. The following are suggested areas that would benefit from randomized trial investigation:

  1. Short (i.e. seven days) versus longer duration β-lactam therapy for pyelonephritis

  2. Even shorter courses (e.g. three days therapy) for nonsevere community-acquired pneumonia

  3. Short versus longer durations of treatment in catheter-associated bacteraemia

  4. Short (i.e. five days) versus longer duration of therapy in severe cellulitis with early clinical response